MARKET

REGN

REGN

Regeneron Pharmaceuticals
NASDAQ
801.82
-2.08
-0.26%
After Hours: 797.97 -3.85 -0.48% 16:48 09/23 EDT
OPEN
805.23
PREV CLOSE
803.90
HIGH
813.53
LOW
790.02
VOLUME
721.06K
TURNOVER
--
52 WEEK HIGH
859.34
52 WEEK LOW
538.24
MARKET CAP
82.55B
P/E (TTM)
19.82
1D
5D
1M
3M
1Y
5Y
1D
Is Regeneron Stock a Bargain Below $800?
The Motley Fool · 1d ago
Here’s How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 20 Years
Benzinga · 1d ago
1 S&P 500 Stock Worth Your Attention and 2 We Ignore
Barchart · 1d ago
Healthcare stocks with the strongest dividend growth grades
Seeking Alpha · 2d ago
Weekly Report: what happened at REGN last week (0914-0918)?
Weekly Report · 2d ago
FDA, Duke-Margolis workshop to examine evidence standards for rare diseases
Seeking Alpha · 3d ago
Itepekimab COPD Extension Trial Completion: What It Means for Regeneron and Sanofi
TipRanks · 5d ago
Trump set to announce MFN pricing for Medicaid in all states
Seeking Alpha · 5d ago
More
About REGN
Regeneron Pharmaceuticals, Inc. is a fully integrated biotechnology company. The Company invents, develops, manufactures, and commercializes medicines for people with serious diseases. Its products and product candidates in development are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. The Company is accelerating drug development using its proprietary technologies, such as VelociSuite, which produces optimized fully human antibodies and new classes of bispecific antibodies. VelociSuite consists of VelocImmune, VelociGene, VelociMouse, VelociMab, Veloci-Bi, VelociT, VelociHum, and other related technologies. Its marketed products include EYLEA (aflibercept); Dupixent (dupilumab); Libtayo (cemiplimab); Ordspono (odronextamab); Kevzara (sarilumab); Itepekimab; Lynozyfic, and others.

Webull offers Regeneron Pharmaceuticals Inc stock information, including NASDAQ: REGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, REGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading REGN stock methods without spending real money on the virtual paper trading platform.